Use of a Digital Psychotherapeutic App to Reduce Symptom Burden in Dermatology Patients
Development and Testing of a Digital Psychological Tool to Improve Symptom Burden in Dermatology Patients
- Eczema
- Psoriasis
- Urticaria
At a glance
- Phase
- Phase not stated
- Study type
- Interventional
- Sponsor
- National University Hospital, Singapore
- Enrolment target
- 690
- Started
- 23 February 2026
- Main results due
- December 2028
- Study sites
- 1
- Registry updated
- 28 September 2026
Can you take part?
- Aged 16 years and over.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria:
* Patients with psoriasis, eczema or chronic urticaria diagnosed by a dermatologist
* Aged 16 or older
* Peak pruritus intensity of 4 or more on a 11-point numerical rating scale (0-10, with 10 representing worst itch)
* Able to engage with a mobile application in the English language
Exclusion Criteria:
* Patients with active psychiatric symptoms (e.g. active suicidal ideation, psychosis, delusions)
* Patients with unstable psychiatric condition, characterized by
o Hospital inpatient admission for a psychiatric condition or initiation of a psychotropic medication in the prior 3 months
* Patients with unstable dermatological condition, characterized by
* Recent flare of the skin condition within the last 2 weeks, including diagnosis of a flare by a doctor, use of systemic steroids, oral antibiotics, wet wrap rescue therapy, oral antivirals, or increase in frequency of phototherapy or dose of systemic medications for the dermatological condition within the last 2 weeks OR
* Any of the following within 3 months
* inpatient admission for a dermatological condition
* Initiation of phototherapy
* Initiation of systemic therapy (conventional immunosuppressive agent, biologics, JAK inhibitors) within the last 3 months.What this study is about
In the sponsor’s own words, from the registry.
Skin diseases, despite low mortality, significantly impair quality of life. This randomised controlled trial evaluates the efficacy of a digital toolkit comprising psychotherapeutic strategies in reducing QoL burden in patients with chronic inflammatory skin conditions. This toolkit is hosted on a mobile application and will be used by study participants randomised to the intervention arm over the 32 week study period.
Study sites(1)
National University Hospital
Singapore, Singapore
Recruiting
Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT06702293. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me